| Serum vascular endothelial growth factor C as a marker of therapeutic response to sirolimus in lymphangioleiomyomatosis N Gupta, M Hagner, H Wu, LR Young, A Palipana, RD Szczesniak, ... Annals of the American Thoracic Society 18 (1), 174-177, 2021 | 4 | 2021 |
| Seasonal variation of lung function in cystic fibrosis: longitudinal modeling to compare a Midwest US cohort to international populations E Gecili, C Brokamp, A Palipana, R Huang, ER Andrinopoulou, T Pestian, ... Science of The Total Environment 776, 145905, 2021 | 3 | 2021 |
| Built environment factors predictive of early rapid lung function decline in cystic fibrosis E Gecili, C Brokamp, E Rasnick, PM Afonso, ER Andrinopoulou, ... Pediatric pulmonology 58 (5), 1501-1513, 2023 | 2 | 2023 |
| Efficiently analyzing large patient registries with Bayesian joint models for longitudinal and time-to-event data PM Afonso, D Rizopoulos, AK Palipana, GC Zhou, C Brokamp, ... arXiv preprint arXiv:2310.03351, 2023 | 1 | 2023 |
| Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis AK Palipana, E Gecili, S Song, SR Johnson, RD Szczesniak, N Gupta Chest 163 (6), 1458-1470, 2023 | 1 | 2023 |
| 43: Monitoring and phenotyping rapid cystic fibrosis disease progression using community characteristics and environmental exposures A Palipana, E Gecili, C Brokamp, E Rasnick, A Vancil, D Ehrlich, T Pestian, ... Journal of Cystic Fibrosis 20, S22, 2021 | 1 | 2021 |
| Seasonality, mediation and comparison (SMAC) methods to identify influences on lung function decline E Gecili, A Palipana, C Brokamp, R Huang, ER Andrinopoulou, T Pestian, ... MethodsX 8, 101313, 2021 | 1 | 2021 |
| Predicting lung function decline in cystic fibrosis: the impact of initiating ivacaftor therapy GC Zhou, Z Wang, AK Palipana, ER Andrinopoulou, P Miranda Afonso, ... Respiratory Research 25 (1), 187, 2024 | | 2024 |
| Bayesian two-stage modeling of longitudinal and time-to-event data with an integrated fractional Brownian motion covariance structure A Palipana, S Song, N Gupta, R Szczesniak Biometrics 80 (1), ujae011, 2024 | | 2024 |
| Efficacy of BETTER transitional care intervention for diverse patients with traumatic brain injury and their families: Study protocol of a randomized controlled trial TO Oyesanya, SO Ibemere, HB You, MM Emerson, W Pan, A Palipana, ... Plos one 19 (2), e0296083, 2024 | | 2024 |
| Social-environmental phenotypes of rapid cystic fibrosis lung disease progression in adolescents and young adults living in the United States AK Palipana, A Vancil, E Gecili, E Rasnick, D Ehrlich, T Pestian, ... Environmental advances 14, 100449, 2023 | | 2023 |
| Evaluating Precision Medicine Tools in Cystic Fibrosis for Racial and Ethnic Fairness SP Colegate, A Palipana, E Gecili, RD Szczesniak, C Brokamp Journal of Clinical and Translational Science, 1-24, 2023 | | 2023 |
| WS15. 02 A joint model for lung function and nutritional status decline with recurrent pulmonary exacerbations, death, and lung transplantation using cystic fibrosis patient … PM Afonso, R Szczesniak, GC Zhou, JP Clancy, A Palipana, E Rasnick, ... Journal of Cystic Fibrosis 21, S29, 2022 | | 2022 |
| WS07. 05 Investigating the relationship between lung function decline and time to death or lung transplantation, accounting for geographical variability ER Andrinopoulou, PM Afonso, R Szczesniak, GC Zhou, JP Clancy, ... Journal of Cystic Fibrosis 21, S14-S15, 2022 | | 2022 |
| Book of Abstracts XVIII Congreso de Biometría CEBMADRID S Cabras, I Cascos Fernández, ME Castellanos, ML Durbán Reguera | | 2022 |
| Univariate and Multivariate Joint Models with Flexible Covariance Structures for Dynamic Prediction of Longitudinal and Time-to-event Data. A Palipana University of Cincinnati, 2022 | | 2022 |
| 34: Predicting declines in lung function with the US CF registry: Impact of initiating highly effective modulator therapy G Zhou, Z Wang, A Palipana, E Andrinopoulou, P Afonso, G McPhail, ... Journal of Cystic Fibrosis 20, S17-S18, 2021 | | 2021 |
| 57: Secular drift in predictive accuracy of pulmonary exacerbations: A registry study Z Wang, G Zhou, A Palipana, E Gecili, J Clancy, R Szczesniak Journal of Cystic Fibrosis 20, S29, 2021 | | 2021 |
| High traffic pollution predicts rapid decline in lung function among children with cystic fibrosis E Gecili, W Su, E Rasnick, P Ryan, A Palipana, Y Ni, E Andrinopoulou, ... ISEE Conference Abstracts 2020 (1), 2020 | | 2020 |
| Monitoring Lymphangioleiomyomatosis Disease Progression with Predictive Probabilities for FEV1 Decline N Gupta, A Palipana, H Lee, S Johnson, FX McCormack, R Szczesniak C38. RARE LUNG DISEASES, A4967-A4967, 2020 | | 2020 |
